Artemis Medicare Services Ltd (ARTEMISMED)
₹342.05
Mkt cap
₹5,438 Cr
P/E ratio
47.10
P/B
5.77
Div yield
0.13%
ROE
11.90%
ROCE
14.50%
EPS (TTM)
₹7.26
Book value
₹59
52W range
206–345
Sector
Healthcare
Price history
Previous close
Artemis Medicare Services Ltd (AMSL) was incorporated in 2004, operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. [1] [2]
NSE ARTEMISMEDBSE 542919
Health check
Constructive
ValuationFair
ProfitabilityAverage
GrowthModerate
TechnicalsBullish
52-week range
−0.71% from high₹342
₹206+66.44% from low₹345
Current
₹342.05
Prev close
₹344.50
Day
−0.71%
Price performance
1D
−0.71%
1W
+4.30%
1M
+8.26%
3M
+32.45%
6M
+46.06%
1Y
+52.13%
YTD
+23.86%
Financials
Revenue, profit & margin
P/E ratio
47.1×
ARTEMISMED is 4% below the sector median of 49.0×
ARTEMISMED47.1×
Sector median49.0×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 201 | 217 | 210 | 217 | 217 | 235 | 227 | 235 | 250 | 270 | 267 | 274 | 282 | |
| Expenses | 174 | 184 | 179 | 181 | 181 | 193 | 190 | 199 | 209 | 220 | 223 | 224 | 227 | |
| Operating Profit | 27 | 33 | 32 | 36 | 36 | 42 | 37 | 36 | 41 | 50 | 44 | 50 | 55 | |
| OPM % | 14% | 15% | 15% | 17% | 16% | 18% | 16% | 15% | 16% | 19% | 16% | 18% | 20% | |
| Other Income | 1 | 2 | 2 | 2 | 4 | 8 | 9 | 12 | 7 | 8 | 4 | 8 | 5 | |
| Interest | 6 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 6 | 6 | |
| Depreciation | 9 | 9 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 12 | 12 | 12 | |
| Profit before tax | 13 | 19 | 16 | 19 | 22 | 31 | 27 | 29 | 30 | 40 | 30 | 39 | 42 | |
| Tax % | 26% | 27% | 29% | 28% | 24% | 27% | 23% | 20% | 29% | 25% | 24% | 25% | 26% | |
| Net Profit | 10 | 14 | 12 | 14 | 17 | 23 | 21 | 23 | 21 | 30 | 23 | 30 | 31 | |
| EPS in Rs | 0.73 | 1.01 | 0.85 | 1.02 | 1.24 | 1.64 | 1.51 | 1.69 | 1.54 | 2.16 | 1.42 | 1.87 | 1.96 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −0.15% · closed higher next day 1 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 3 Aug '26◦ |
| Earnings day | −0.15% |
| +1 day | +6.60% |
| +5 days | +3.67% |
| +15 days | +7.11% |
| +30 days | — |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Jun 202658.39%Promoter
Promoters58.39%
FIIs12.28%0.09
DIIs2.40%0.49
Public20.76%0.39
Government6.16%
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹8,760.00 | 59.87 | 1,25,955 | 0.23% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| MAXHEALTH | ₹992.00 | 64.49 | 96,552 | 0.20% | 323 | +4.87% | 2,366 | +16.70% | 14.71% |
| MANIPALHOS | ₹727.25 | 108.04 | 95,661 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| ASTERDM | ₹795.65 | 192.15 | 69,355 | 0.38% | 29 | −46.12% | 1,311 | +21.60% | 11.40% |
| FORTIS | ₹910.00 | 64.40 | 68,701 | 0.11% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| NH | ₹1,911.80 | 45.33 | 39,070 | 0.24% | 207 | +5.71% | 2,684 | +78.05% | 15.50% |
| MEDANTA | ₹1,422.60 | 66.81 | 38,250 | 0.04% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| ARTEMISMED | ₹343.50 | 47.12 | 5,438 | 0.13% | 31 | +44.96% | 282 | +12.89% | 14.53% |
| Median: 29 Co. | ₹518.25 | 48.95 | 6,639 | 0.04% | 31 | +18.98% | 406 | +22.28% | 14.71% |
Filings
Annual reports7
Concall transcripts23
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 27 Aug - Analysts/ Institutional Investors' Conference - September 3, 2026Announcement under Regulation 30 (LODR)-Earnings Call Transcript 10 Aug - Transcript of Earnings Conference Call - Q1 FY27Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 10 Aug - Artemis Medicare will participate in EMKAY Confluence 2026 investor conference in Mumbai on August 13, 2026.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 4 Aug - Audio recording of Q1 FY27 earnings conference call made available on company website.Announcement under Regulation 30 (LODR)-Newspaper Publication 4 Aug






